Explore › Finding
Finding improvement
Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining significant after adjustment for CD4 count and viral load.
Effect sizeRH = 0.46
CI95% CI: 0.23-0.91
Follow-up24 months
ComparatorPre-ART availability era (same cohort before HIV treatment program started in 2004)
Effect summaryimprovement; RH = 0.46; CI: 95% CI: 0.23-0.91

Connected entities

Interventions
Patient Access to Records
Conditions
HIV infection
Outcomes
All-cause mortality
Populations
Pregnant Women

Source

PMC2782481
Mortality and virologic outcomes following access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia
Read on PMC → · View in graph →